Lili Jiang1, Yunmei Yu2, Wei Zeng3, Jiafan Guo1, Fei Lv1, Xin Wang1, Xiaoliu Liu4, Zuguo Zhao5. 1. Department of Microbiology and Immunology of Guangdong Medical University, Zhanjiang, Guangdong Province, China. 2. Clinical lab of 422nd Center Hospital of the People' Liberation Army, Zhanjiang, Guangdong Province, China. 3. Department of Neurology, Fifth Hospital (Second Hospital Affiliated to Jianghan University) of Wuhan City, Wuhan, China. 4. Medical Laboratory of ShenZhen LuoHu People's Hospital, Shenzhen, Guangdong Province, China. 5. Department of Microbiology and Immunology of Guangdong Medical University, Zhanjiang, Guangdong Province, China. Electronic address: zhaozuguo@gdmu.edu.cn.
Abstract
OBJECTIVE: Infections caused by multidrug-resistant Acinetobacter spp. have generated worldwide attention. With the increasing isolation of non-baumannii Acinetobacter, the nature of associated infection and resistance needs to be explored. This study aimed to analyse the characteristics of New Delhi Metallo-Beta-Lactamase-1 (NDM-1)-producing Acinetobacter haemolyticus (named sz1652) isolated from Shenzhen city, China. METHODS: The antibiotic spectrum was analysed after antimicrobial susceptibility testing. Combined disk test (CDT) was used to detect the metallo-beta-lactamases (MBLs). Transferability of carbapenem resistance was tested by filter mating experiments and plasmid transformation assays. Whole-genome sequencing (WGS) was performed using HiSeq 2000 and PacBio RS system. RESULTS: The Acinetobacter haemolyticus strain sz1652 was resistant to carbapenems and other tested agents except for amikacin, tigecycline and colistin. Production of MBLs was confirmed by CDT. Transfer of carbapenem resistance was unsuccessful. WGS analysis showed that the genome of sz1652 comprised a chromosome and two plasmids; 16 genomic islands (GIs) were predicted. Genes associated with resistance were found in this strain, including the beta-lactamase genes blaNDM-1, blaOXA-214 and blaLRA-18, the fluoroquinolone resistant-related mutations [GyrA subunits (Ser81Ile) and ParC subunits (Ser84Tyr)], and efflux pump genes related to tetracycline and macrolide resistance. Analysis of the genetic environment showed that blaNDM-1 was embedded in Tn125 transposon. The Tn125 structure was chromosomally located and shared > 99% sequence identity with the previously reported blaNDM-1 carrying region. CONCLUSION: The NDM-1-producing Acinetobacter haemolyticus coexisted with multiple drug-resistant determinants. The acquisition of the blaNDM-1 gene was probably facilitated by Tn125 in this strain. Non-Acinetobacter baumannii species also contained GIs.
OBJECTIVE: Infections caused by multidrug-resistant Acinetobacter spp. have generated worldwide attention. With the increasing isolation of non-baumannii Acinetobacter, the nature of associated infection and resistance needs to be explored. This study aimed to analyse the characteristics of New Delhi Metallo-Beta-Lactamase-1 (NDM-1)-producing Acinetobacter haemolyticus (named sz1652) isolated from Shenzhen city, China. METHODS: The antibiotic spectrum was analysed after antimicrobial susceptibility testing. Combined disk test (CDT) was used to detect the metallo-beta-lactamases (MBLs). Transferability of carbapenem resistance was tested by filter mating experiments and plasmid transformation assays. Whole-genome sequencing (WGS) was performed using HiSeq 2000 and PacBio RS system. RESULTS: The Acinetobacter haemolyticus strain sz1652 was resistant to carbapenems and other tested agents except for amikacin, tigecycline and colistin. Production of MBLs was confirmed by CDT. Transfer of carbapenem resistance was unsuccessful. WGS analysis showed that the genome of sz1652 comprised a chromosome and two plasmids; 16 genomic islands (GIs) were predicted. Genes associated with resistance were found in this strain, including the beta-lactamase genes blaNDM-1, blaOXA-214 and blaLRA-18, the fluoroquinolone resistant-related mutations [GyrA subunits (Ser81Ile) and ParC subunits (Ser84Tyr)], and efflux pump genes related to tetracycline and macrolide resistance. Analysis of the genetic environment showed that blaNDM-1 was embedded in Tn125 transposon. The Tn125 structure was chromosomally located and shared > 99% sequence identity with the previously reported blaNDM-1 carrying region. CONCLUSION: The NDM-1-producing Acinetobacter haemolyticus coexisted with multiple drug-resistant determinants. The acquisition of the blaNDM-1 gene was probably facilitated by Tn125 in this strain. Non-Acinetobacter baumannii species also contained GIs.
Authors: Mark D Adams; Fernando Pasteran; German M Traglia; Jasmine Martinez; Fanny Huang; Christine Liu; Jennifer S Fernandez; Carolina Lopez; Lisandro J Gonzalez; Ezequiel Albornoz; Alejandra Corso; Alejandro J Vila; Robert A Bonomo; Maria Soledad Ramirez Journal: Antimicrob Agents Chemother Date: 2020-04-21 Impact factor: 5.191